4d Molecular Therapeutics Inc Revenue per Employee (FDMT), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
4d Molecular Therapeutics Inc   (NASDAQ: FDMT)
 

4d Molecular Therapeutics Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 25106.67% in the second quarter 2026, year on year to cumulative value of $92 million, 4d Molecular Therapeutics Inc 's revenue per employee grew on a trailing twelve months basis to $ 469,429, this marks a new company high.
Within the Healthcare sector Employees of 206 other companies have achieved higher revenue per employee. While 4d Molecular Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 1389 to 1786. 4d Molecular Therapeutics Inc has 196 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FDMT Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 25106.67 % 21664.29 % 8508900 % 2900 % 200 %
Sales per Employee (TTM) $ 469,429 450,214 434,740 612 168
FDMT's Total Ranking # 1786 # 1389 # 944 # 0 # 2631
Seq. Revenue Change 24.09 % -96.42 % 94444.44 % 500 % 7.14 %

FDMT Company Profile >> Back to FDMT Efficiency Comparisons >> Compare FDMT Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 28
Healthcare Sector # 207
Overall Market # 1786

Revenue per Employee Statistics
High Average Low
$ 469,429 $ 106,553 $ 92
(Jun 30 2026)   (Sep 30 2024)



Financial Statements
4d Molecular Therapeutics Inc 's Revenue MRQ $ 4 Millions Visit FDMT's Income Statement
4d Molecular Therapeutics Inc 's Revenues TTM $ 92 Millions Visit FDMT's aggregate revenue growth
What are FDMT's Sales? Visit FDMT's Sales by Segment




Other Ratios
4d Molecular Therapeutics Inc 's Income per Employee
Employees in Biotechnology & Pharmaceuticals
Biotechnology & Pharmaceuticals Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
FDMT's Revenue per Employee versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for FDMT's Competitors
Revenue per Employee for FDMT's Suppliers
Revenue per Employee for FDMT's Customers

You may also want to know
FDMT's Sales Growth Rates FDMT's Pe Price to earnings ratio FDMT's Receivables Turnover Ratio FDMT's Stock Quote
FDMT's Net Income Growth Rates FDMT's Ps Price to Sales ratio FDMT's Sales per Employee FDMT's Asset Turnover Ratio
FDMT's Net Margin FDMT's Pb Price to Book ratio FDMT's Financial Strength Ratios FDMT's Dividend Payout Ratio
Date modified: 2026-09-03T11:45:51+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Prothena Corporation Public Limited Company  813,880.60 $ 54.530  Million 67 
Alkermes Plc   813,488.78 $ 1,667.652  Million 2,050 
Lifevantage Corp  811,421.52 $ 180.947  Million 223 
Sanuwave Health Inc   798,236.36 $ 43.903  Million 55 
Septerna Inc   760,630.77 $ 98.882  Million 130 
Dyadic International Inc   760,447.40 $ 3.802  Million 5 
Transmedics Group Inc   744,396.44 $ 668.468  Million 898 
Aveanna Healthcare Holdings Inc   743,662.86 $ 2,602.820  Million 3,500 
Veracyte Inc   721,503.31 $ 544.735  Million 755 
Xtant Medical Holdings Inc   720,185.43 $ 108.748  Million 151 
Harrow Inc   719,172.77 $ 274.724  Million 382 
Ars Pharmaceuticals Inc   717,343.56 $ 116.927  Million 163 
Sunshine Biopharma Inc   706,935.44 $ 35.347  Million 50 
Johnson and Johnson  695,518.47 $ 97,929.000  Million 140,800 
Intuitive Surgical Inc   663,668.41 $ 11,296.300  Million 17,021 
Biolife Solutions Inc   662,696.77 $ 102.718  Million 155 
Zoetis Inc   656,344.83 $ 9,517.000  Million 14,500 
Urogen Pharma Ltd   647,137.46 $ 188.317  Million 291 
Insmed Inc  646,978.37 $ 1,076.572  Million 1,664 
Premier Air Charter Holdings Inc   644,120.78 $ 31.562  Million 49 
Karyopharm Therapeutics Inc   643,074.56 $ 146.621  Million 228 
Evofem Biosciences Inc   622,241.38 $ 18.045  Million 29 
Nexgel Inc   621,578.95 $ 11.810  Million 19 
Bioventus Inc   618,197.87 $ 581.106  Million 940 
Organon and Co   613,900.00 $ 6,139.000  Million 10,000 
Nature s Sunshine Products inc   610,161.29 $ 491.790  Million 806 
Delcath Systems Inc   602,935.90 $ 94.058  Million 156 
Nephros Inc   602,388.89 $ 21.686  Million 36 
Jaguar Health Inc   591,808.51 $ 27.815  Million 47 
Milestone Scientific Inc   590,317.47 $ 8.855  Million 15 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.